跳至主要内容
临床试验/NCT00720915
NCT00720915已完成不适用

A Cohort Study to Test That There is a Low Risk of Recurrent VTE in Patients With a First Episode of Unprovoked VTE Who Stop Anticoagulant Therapy After 3 Months of Treatment in Response to Negative D-dimer Testing

McMaster University25 个研究点 分布在 4 个国家目标入组 410 人开始时间: 2008年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
410
试验地点
25
主要终点
Suspected Recurrent DVT

研究概览

简要总结

The purpose of this study is to determine if the risk of recurrent venous thromboembolism (VTE) after stopping therapy is low and acceptable in patients with a first unprovoked proximal deep vein thrombosis (DVT) or pulmonary embolism (PE) who have completed 3 months of therapy and who have a negative D-dimer test on therapy and 1 month after stopping therapy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be >= 18 years of age
  • Have had ONE episode of unprovoked proximal DVT and/or PE
  • Have completed 3 uninterrupted months of warfarin therapy (target INR of 2.0-3.0)

排除标准

  • Another indication for long-term anticoagulation (e.g., atrial fibrillation)
  • A high risk of bleeding as evidenced by any of the following:
  • Age greater than 75 years
  • Previous episode of major bleeding where the cause was not effectively treated
  • Known chronic thrombocytopenia with a platelet count of less than 120,000 x 10^9 /L
  • Known chronic renal impairment with a creatinine of more than 150 mumols /litre (1.7 mg/dl)
  • Known chronic liver disease with a total bilirubin of more than 25 mumols /litre (1.5 mg/dl)
  • Active peptic ulcer disease
  • Poor compliance with, or control of, anticoagulant therapy during initial treatment
  • Requires dual antiplatelet therapy (e.g. aspirin and clopidogrel)
  • A vena caval filter
  • Has had D-dimer testing performed within 2 months of potential enrollment other than for evaluation of suspected recurrent VTE that was not confirmed
  • Has a life expectancy less than 5 years
  • Is unable to attend follow-up visits because of geographic inaccessibility
  • Is participating in a competing clinical investigation

结局指标

主要结局

Suspected Recurrent DVT

时间窗: up to 7 years

Suspected (recurrent) pulmonary embolism

时间窗: up to 7 years

Bleeding

时间窗: up to 7 years

Death

时间窗: up to 7 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (25)

Loading locations...

相似试验